10.27.17 | Alzheimer's Disease
Imaging The Effects Of Menopausal Hormone Therapy On The Brain
Imaging provides a window into brain changes due to dementia decades before someone begins to show clinical symptoms of the disease. Volume of the brain gradually declines with advancing age, but this decline takes a faster course in people who experience more cognitive decline than is expected for their age and go on to develop dementia.
10.27.17 | Alzheimer's Disease
The Importance Of Revamping The Guidelines For Alzheimer’s Disease
An estimated 5.2 million Americans live with Alzheimer’s disease. Of these Americans, 5 million are over the age of 65 years old. AD is the third leading cause of death in older adults, and is the only top 10 cause of death in the U.S. with no disease modifying treatment or proven treatment for prevention.
10.19.17 | Migraine
SWHR Engages on Migraine and Women’s Health
SWHR convened interdisciplinary thought leaders at the George Washington University Milken School of Public Health for a panel discussion that included patients, practitioners, and the employer perspective.
10.19.17
SWHR Elects Roberta L. Gartside as Incoming Board Chair
SWHR announced the unanimous election of Roberta L. Gartside, MD, as the new Chair of its Board of Directors for 2018-2019. As a business leader with a strong commitment to nonprofit service, Dr. Gartside will lead the organization’s mission-based efforts to eliminate imbalances in care for women through science, advocacy, and education.
8.21.17
SWHR Lauds Passage and Signage of FDA Reauthorization Act of 2017 into Law
SWHR congratulates the Congress and the President for approving the Food and Drug Administration (FDA) Reauthorization Act of 2017. By providing significant funding and important improvements to FDA's medical products review and approval process, this law will enable timely access to safe and effective medical innovations to millions of patients who need them.
7.12.17
SWHR Elects Two New Members to Board of Directors
SWHR announced the election of two new members to its Board of Directors: Gretta Stone, Deputy Vice President of Policy & Research at PhRMA and Dawn Halkuff, Chief Commercial Officer at TherapeuticsMD.
7.10.17
Exploring Sex Differences in Alzheimer’s: Risk Factors Across the Lifespan
There are undoubtedly different sets of Alzheimer's disease risk factors that impact women versus men and these factors are likely to exert changes at different points in the lifespan.
6.7.17 | Alzheimer's Disease
Menopause, Memory, and Alzheimer’s Disease
When women think about menopause, they typically think about hot flashes. New research shows that memory problems are a common but under-recognized menopausal symptom.
5.30.17 | Obesity
Obesity-related Eating Disorders in Women
In the U.S., more than four in ten women are obese, compared to a little more than a third of men.
